Trade secrets and dominant positions of this kind #multinationals make healthcare institutions vulnerable. The Dutch policy of sparse testing on the coronavirus is largely motivated by a shortage of laboratory materials. Pharmaceutical Roche has a prescription for the liquid that can be used to test people for Corona. In the Netherlands, 80% of laboratories depend on the products of this company. This creates problems, because the demand for testing is huge and Roche can't handle this question. How great is the power of these companies in times of crisis? Can we arrange the proportions better in the future? In this program, investigative journalists engage with experts.



How can we improve the dominant position of suppliers to healthcare institutions in the future?